FDA authorizes Pfizer booster for older & at-risk Americans
The U.S. moved a step closer Wednesday to offering booster doses of Pfizer's covid-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots.
